Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | LIF | 88.0 | 51 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | LIF | 79.0 | 40 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | LIF | 88.0 | 52 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | LIF | 106.0 | 53 | |
RA2159 | Sigma A6730 | 3.0 | uM | 1 | LIF | 84.0 | 56 | ||||
N2586 | IL-6 | 100 | ug/mL | 1 | LIF | 133.0 | 55 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | LIF | 119.0 | 45 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | LIF | 108.5 | 52 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | LIF | 116.0 | 40 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | LIF | 123.0 | 44 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | LIF | 119.5 | 44 | |
N2586 | Sigma A6730 | 3.0 | uM | 1 | LIF | 149.0 | 30 | ||||
RA2159 | IL-17A | 100 | ng/mL | 1 | LIF | 87.0 | 59 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | LIF | 86.5 | 50 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | LIF | 82.0 | 55 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | LIF | 71.5 | 66 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | LIF | 81.5 | 64 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | LIF | 94.0 | 63 | |
N2586 | IL-17A | 100 | ng/mL | 1 | LIF | 174.5 | 30 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | LIF | 150.0 | 42 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | LIF | 201.0 | 19 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | LIF | 163.5 | 34 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | LIF | 115.5 | 28 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | LIF | 150.0 | 47 | |
RA2159 | 1 | LIF | 89.5 | 46 |